AMGN FEATURED NEWS & ANALYSIS
LATEST ABOUT THIS TOPIC ON CNBC.COM
-
Final Glance: Biotechnology companies 11 hrs ago - The Associated Press
-
Amag slumps on Ferahame recall in Switzerland 15 hrs ago - The Associated Press
-
Midday Glance: Biotechnology companies 16 hrs ago - The Associated Press
-
Early Glance: Biotechnology companies 18 hrs ago - The Associated Press
-
Immune system cancer drugs tipped to be a $35 bln market 22 May 2013 - Reuters
-
Final Glance: Biotechnology companies 21 May 2013 - The Associated Press
-
Midday Glance: Biotechnology companies 21 May 2013 - The Associated Press
-
Early Glance: Biotechnology companies 21 May 2013 - The Associated Press
-
Lightning Round: CarMax, Asbury Automotive & More 20 May 2013 - CNBC.com
-
Final Glance: Biotechnology companies 20 May 2013 - The Associated Press
MORE FROM CNBC
-
Lightning Round: CarMax, Asbury Automotive & More 20 May 2013 - CNBC.com
-
Early Movers: CMCSA, MRK & More 01 May 2013 - CNBC.com
-
-
-
'Utterly Absurd' Stock Rally: Josh Brown 26 Apr 2013 - CNBC.com
-
-
Stock Market's Defensive Line Takes a Hit 24 Apr 2013 - CNBC.com
-
Cramer: Sellers Clobbering Stocks Recklessly? 24 Apr 2013 - CNBC.com
-
-
MORE FROM OUR PARTNERS
-
1 Biotech, 1 Financial And 1 Consumer Goods Company With Recent Intens... 18 hrs ago - Seeking Alpha
-
AbbVie Reaches New Highs Thanks To Humira 21 hrs ago - Seeking Alpha
LATEST TRANSCRIPTS
-
Amgen, Inc. Management Presents at UBS Global Healthcare Conference (T... 21 May 2013 - Seeking Alpha
-
Amgen's CEO Discusses Q1 2013 Results - Earnings Call Transcript 23 Apr 2013 - Seeking Alpha
PRESS RELEASES
-
Amgen Announces Voting Results of Annual Meeting of Stockholders 11 hrs ago - PR Newswire
-
NPS Pharmaceuticals to Present at Deutsche Bank Health Care Conference 13 hrs ago - Business Wire
-
NPS Pharmaceuticals Prices Public Offering of Common Stock 21 May 2013 - Business Wire
-
U.S. Renal Care pays $7.3 million to settle billing fraud case brought... 21 May 2013 - PR Newswire
-
RBCC Opens Talks to Acquire Tech Innovators in $142 Billion Drug Deliv... 21 May 2013 - Business Wire
-
NPS Pharmaceuticals Announces Proposed Public Offering of 6,000,000 Sh... 20 May 2013 - Business Wire
-
Ignyta Announces Acquisition of Actagene Oncology and Entry into Oncol... 20 May 2013 - Business Wire
-
Royalty Pharma Increases Offer for Elan to $12.50 Per Share in All Cas... 20 May 2013 - PR Newswire
-
TechAtlas Group Releases Innovative Chronic Kidney Disease Landscape M... 17 May 2013 - PR Newswire
-
Nektar Therapeutics' President and CEO, Howard W. Robin, To Present at... 16 May 2013 - PR Newswire
